Tradestie Institutional Equity Comparison Engine
BMRA vs AVR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AVR Overall Edge
AVR Captures Institutional Edge (3โ0 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Anteris Technologies Global Corp. Common Stock (AVR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BMRA trades at N/M Forward P/E with -125.2% operating margin (-8.3% YoY revenue) versus AVR at N/M Forward P/E and -4880.4% operating margin (+21.0% YoY). In options structure, BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AVR sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BMRA N/M vs AVR N/M Fwd P/E
Growth & Margin Winner
AVR
Op Margin -125.2% vs -4880.4% ยท YoY -8.3% vs +21.0%
Momentum & Technical Winner
AVR
1Y -45.6% vs +46.2% ยท 52W Pos 5% vs 29%
Options & Structure Winner
AVR
UNCLASSIFIED (N/A IV) vs BREAKDOWN (52nd %ile IV)
BMRA
NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.36
+0.0% 1D
Market Cap
$6.0M
1M Return
-26.49%
1Y Return
-45.6%
Forward P/E
N/M
Unified AI Score
44.5 / 100
HOLD
Tech 40.0
Fund 47.0
Flow 50.0
Mom 44.0
AVR
NASDAQ
Anteris Technologies Global Corp. Common Stock
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$5.54
+2.21% 1D
Market Cap
$570.4M
1M Return
-8.43%
1Y Return
+46.17%
Forward P/E
N/M
Unified AI Score
41.2 / 100
SELL
Tech 31.0
Fund 49.0
Flow 57.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BMRA -45.6%
AVR +46.17%
Spread: +91.77 pp (AVR Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BMRA Revenue | AVR Revenue | BMRA Op. Margin | AVR Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | N/A | -46.4% | N/A | BMRA |
| FY2020 | $10M | N/A | -41.0% | N/A | BMRA |
| FY2021 | $10M | N/A | -104.2% | N/A | BMRA |
| FY2022 | $20M | N/A | -24.0% | N/A | BMRA |
| FY2023 | $10M | N/A | -135.3% | N/A | BMRA |
| FY2024 | $10M | $0M | -117.6% | -2899.4% | BMRA |
| FY2025 | $10M | $0M | -96.7% | -4908.2% | BMRA |
| FY2026 | $0M | N/A | -119.5% | N/A | BMRA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BMRA | AVR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.0M | $570.4M | Larger Scale | AVR |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -8.3% | +21.0% | Higher Growth | AVR |
| Operating Margin (TTM) Profitability | -125.2% | -4880.4% | Higher Margin | BMRA |
| Net Profit Margin Profitability | -115.5% | 0.0% | Higher Margin | AVR |
| Return on Equity (ROE) Capital Efficiency | -113.8% | -93.3% | Higher ROE | AVR |
| 52-Week Range Position Momentum | 5% ($1โ$3) | 29% ($3โ$11) | Stronger Trend | AVR |
| Beta / 30D Volatility Risk Regime | 0.67ฮฒ ยท 62% Vol | 1.58ฮฒ ยท 76% Vol | Lower Realized Risk | BMRA |
| Unified Institutional Score Composite Signal | 44.5 / 100 (HOLD) | 41.2 / 100 (SELL) | Higher Composite | BMRA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BMRA vs AVR Buy Guide
BMRA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AVR
BREAKDOWN
101d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
52nd %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BMRA nor AVR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.